Bio Vitos Pharma AB (publ) (STO:BIOVIT)
0.1200
-0.0050 (-4.00%)
Inactive · Last trade price
on Apr 11, 2025
Bio Vitos Pharma AB Company Description
Bio Vitos Pharma AB (publ) operates as a medical technology company in Sweden and internationally.
The company develops and commercializes Helge, which detects hemolysis in vacuum tubes and blood gas samples.
It serves emergency departments in the European Union and the United States. It has a collaboration agreement with KFUM Kalmar to conduct a research study.
The company was formerly known as Hemcheck Sweden AB (publ) and changed its name to Bio Vitos Pharma AB (publ) in December 2023.
Bio Vitos Pharma AB (publ) was incorporated in 2010 and is based in Solna, Sweden.
Bio Vitos Pharma AB (publ)
Country | Sweden |
Founded | 2010 |
Industry | Surgical and Medical Instruments and Apparatus |
Employees | 1 |
CEO | Jesper Birgemo |
Contact Details
Address: Nanna Svartz väg 4 Solna, 171 65 Sweden | |
Phone | 46 5 42 02 22 11 |
Website | biovitospharma.com |
Stock Details
Ticker Symbol | BIOVIT |
Exchange | Nasdaq Stockholm |
Fiscal Year | January - December |
Reporting Currency | SEK |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Jesper Birgemo | Chief Executive Officer |